DWA
CTSO icon

Douglass Winthrop Advisors’s Cytosorbents Corp CTSO Stock Holding History

Douglass Winthrop Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-70,540
Closed -$451K – 241
2016
Q3 		$451K Hold
70,540
– – 0.03% 164
2016
Q2 		$321K Buy
+70,540
New +$307K 0.02% 186

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Douglass Winthrop Advisors's CTSO Position: Q4 2016 in Review

Douglass Winthrop Advisors sold out of Cytosorbents Corp (CTSO) in Q4 2016, closing a stake of 70,540 shares — an estimated $451K sold.

Douglass Winthrop Advisors first reported a position in CTSO in Q2 2016 and held it in 2 quarters. The position peaked at $451K in Q3 2016. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

  • Douglass Winthrop Advisors reported no remaining Cytosorbents Corp position as of Q4 2016 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 70,540 Cytosorbents Corp shares in Q4 2016, an estimated $451K.
  • Douglass Winthrop Advisors first reported a position in Cytosorbents Corp in Q2 2016 and held it in 2 quarters.
  • Douglass Winthrop Advisors's Cytosorbents Corp position peaked at $451K in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.